AAAAAA

   
Results: 1-17 |
Results: 17

Authors: Liang, Y Cincotta, AH
Citation: Y. Liang et Ah. Cincotta, Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of circulating norepinephrine in ob/ob mice, INT J OBES, 25(5), 2001, pp. 698-704

Authors: Jetton, TL Liang, Y Cincotta, AH
Citation: Tl. Jetton et al., Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice, METABOLISM, 50(11), 2001, pp. 1377-1384

Authors: Kraszewski, KZ Cincotta, AH
Citation: Kz. Kraszewski et Ah. Cincotta, Increased responsiveness of ventromedial hypothalamic neurons to norepinephrine in obese versus lean mice: Relation to the metabolic syndrome, INT J MOL M, 5(4), 2000, pp. 349-355

Authors: Cincotta, AH Luo, SQ Liang, Y
Citation: Ah. Cincotta et al., Hyperinsulinemia increases norepinephrine metabolism in the ventromedial hypothalamus of rats, NEUROREPORT, 11(2), 2000, pp. 383-387

Authors: Luo, SQ Luo, J Cincotta, AH
Citation: Sq. Luo et al., Association of the antidiabetic effects of bromocriptine with a shift in the daily rhythm of monoamine metabolism within the suprachiasmatic nuclei of the Syrian hamster, CHRONOBIO I, 17(2), 2000, pp. 155-172

Authors: Boundy, VA Cincotta, AH
Citation: Va. Boundy et Ah. Cincotta, Hypothalamic adrenergic receptor changes in the metabolic syndrome of genetically obese (ob/ob) mice, AM J P-REG, 279(2), 2000, pp. R505-R514

Authors: Cincotta, AH Luo, SQ Zhang, Y Liang, Y Bina, KG Jetton, TL Scislowski, PWD
Citation: Ah. Cincotta et al., Chronic infusion of norepinephrine into the VMH of normal rats induces theobese glucose-intolerant state, AM J P-REG, 278(2), 2000, pp. R435-R444

Authors: Pijl, H Ohashi, S Matsuda, M Miyazaki, Y Mahankali, A Kumar, V Pipek, R Iozzo, P Lancaster, JL Cincotta, AH DeFronzo, RA
Citation: H. Pijl et al., Bromocriptine - A novel approach to the treatment of type 2 diabetes, DIABET CARE, 23(8), 2000, pp. 1154-1161

Authors: Bina, KG Cincotta, AH
Citation: Kg. Bina et Ah. Cincotta, Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice, NEUROENDOCR, 71(1), 2000, pp. 68-78

Authors: Luo, SQ Luo, J Cincotta, AH
Citation: Sq. Luo et al., Suprachiasmatic nuclei monoamine metabolism of glucose tolerant versus intolerant hamsters, NEUROREPORT, 10(10), 1999, pp. 2073-2077

Authors: Keisari, Y Cincotta, E Meier, AH Cincotta, AH
Citation: Y. Keisari et al., Timed daily administration of prolactin and corticosteroid hormone reducesmurine tumor growth and enhances immune reactivity, CHRONOBIO I, 16(3), 1999, pp. 315-333

Authors: Scislowski, PWD Tozzo, E Zhang, Y Phaneuf, S Prevelige, R Cincotta, AH
Citation: Pwd. Scislowski et al., Biochemical mechanisms responsible for the attenuation of diabetic and obese conditions in ob/ob mice treated with dopaminergic agonists, INT J OBES, 23(4), 1999, pp. 425-431

Authors: Hendrzak-Henion, JA Knisely, TL Cincotta, L Cincotta, E Cincotta, AH
Citation: Ja. Hendrzak-henion et al., Role of the immune system in mediating the antitumor effect of benzophenothiazine photodynamic therapy, PHOTOCHEM P, 69(5), 1999, pp. 575-581

Authors: Luo, SQ Luo, J Cincotta, AH
Citation: Sq. Luo et al., Chronic ventromedial hypothalamic infusion of norepinephrine and serotoninpromotes insulin resistance and glucose intolerance, NEUROENDOCR, 70(6), 1999, pp. 460-465

Authors: Luo, SQ Liang, Y Cincotta, AH
Citation: Sq. Luo et al., Intracerebroventricular administration of bromocriptine ameliorates the insulin-resistant/glucose-intolerant state in hamsters, NEUROENDOCR, 69(3), 1999, pp. 160-166

Authors: Zhang, Y Scislowski, PWD Prevelige, R Phaneuf, S Cincotta, AH
Citation: Y. Zhang et al., Bromocriptine/SKF38393 treatment ameliorates dyslipidemia in ob/ob mice, METABOLISM, 48(8), 1999, pp. 1033-1040

Authors: Liang, Y Luo, SQ Cincotta, AH
Citation: Y. Liang et al., Long-term infusion of norepinephrine plus serotonin into the ventromedial hypothalamus impairs pancreatic islet function, METABOLISM, 48(10), 1999, pp. 1287-1289
Risultati: 1-17 |